Dodecanamide, 3-?hydroxy-?N-?(tetrahydro-?2-?oxo-?3-?furanyl)?-
|
- $253 - $1008
- Product name: Dodecanamide, 3-?hydroxy-?N-?(tetrahydro-?2-?oxo-?3-?furanyl)?-
- CAS: 182359-60-0
- MF: C16H29NO4
- MW: 299.41
- EINECS:
- MDL Number:MFCD16875424
- Synonyms:N-(3-Hydroxydodecanoyl)-DL-hoMoserine lactone;3-Hydroxy-N-(tetrahydro-2-oxo-3-furanyl)dodecanamide;3-hydroxy-N-(2-oxooxolan-3-yl)dodecanamide;Dodecanamide, 3-hydroxy-N-(tetrahydro-2-oxo-3-furanyl)-
3 prices
Selected condition：
Brand
- Adipogen Life Sciences
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 10MG
- 250mg
- ManufacturerAdipogen Life Sciences
- Product numberCDX-H0081-M250
- Product descriptionN-(3-Hydroxydodecanoyl)-DL-homoserine lactone ≥97%(HPLC)
- Packaging250mg
- Price$1008
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAAA0003702
- Product descriptionN-(3-HYDROXYDODECANOYL)-DL-HOMOSERINE LACTONE 95.00%
- Packaging10MG
- Price$694.3
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number53727
- Product descriptionN-(3-Hydroxydodecanoyl)-DL-homoserine lactone ≥97% (HPLC)
- Packaging10mg
- Price$253
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Adipogen Life Sciences | CDX-H0081-M250 | N-(3-Hydroxydodecanoyl)-DL-homoserine lactone ≥97%(HPLC) | 250mg | $1008 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | AAA0003702 | N-(3-HYDROXYDODECANOYL)-DL-HOMOSERINE LACTONE 95.00% | 10MG | $694.3 | 2021-12-16 | Buy |
| Sigma-Aldrich | 53727 | N-(3-Hydroxydodecanoyl)-DL-homoserine lactone ≥97% (HPLC) | 10mg | $253 | 2024-03-01 | Buy |
Properties
Boiling point :532.2±50.0 °C(Predicted)
Density :1.06±0.1 g/cm3(Predicted)
storage temp. :-20°C
pka :14.24±0.20(Predicted)
Density :1.06±0.1 g/cm3(Predicted)
storage temp. :-20°C
pka :14.24±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|